Anthony’s role at Aviva Investors is to manage the Global Liquidity business, and head the sales effort that is responsible for managing assets under management of £40bn, covering our Dublin domiciled AAA fund range and French domestic (‘FCP’) short-term money market and money market funds. He has been running the liquidity business for five years and has been in the team, and at Aviva Investors, for the last 10 years. Anthony has also been aligned to the cash liquidity business since 2006. He currently sits as a member of the Liquidity Board for Aviva Investors.
Experience and qualifications
Anthony is knowledgeable in a wide range of traded financial instruments and markets (FX, Money Market, Commodities and Derivative product expertise) with a proven track-record in establishing and developing client relationships at executive level. His specialties include new cash liquidity business development / sales and pipeline management, customer relationship management and retention. Prior to joining Aviva Investors, Anthony performed these duties as Head of Sales at SunGard Wealth Management, ICAP plc and BGC partners.
He is SFA qualified and has 33 years’ experience within financial markets.
Sales Director, Liquidity - UK Corporates
Head of UK Liquidity Portfolio Management
Sales Director, Liquidity – Europe
Senior Portfolio Manager
Head of Credit
Sales Director, Liquidity – Financial Institutions
Senior Credit Research Analyst, Global Sector Lead for Real Estate, Infrastructure & Structured Finance
You might also be interested in
Strategies to change the financial system: An interview with Natalie Mangondo
16 Aug. 2022
Can society reform the system that has enabled growth but simultaneously brought the long-term health of the planet into question? UN Climate Change High Level Champions Finance Youth Fellow Natalie Mangondo contemplates choices and change with AIQ.
Zero-COVID: China’s costly policy error
10 Aug. 2022
Beijing’s ideological battle to stamp out COVID-19 appears increasingly misguided as the rest of the world learns to live with the virus. But the impact of China’s approach will be felt far beyond its borders.
Illiquidity premia in real assets: Q2 2022
9 Aug. 2022
Our real assets research team crunch the data to see whether the effects of rising inflation and interest rates are being reflected in private market returns.
What does the data say? Are we close to 1970’s-style stagflation?
29 Jul. 2022
In this month’s instalment of our visual series on topical themes, we look at whether the global economy is heading towards stagflation.
Multi-asset allocation views: Is this the end of the 60/40 strategy?
20 Jul. 2022
Government bonds have not acted as safe haven assets recently. Sunil Krishnan explores whether this spells the end of the traditional 60/40 allocation in multi-asset portfolios.
The AIQ Podcast: Taking stock of nature risk
15 Jul. 2022
The idea that human actions are bringing natural systems close to breakdown, threatening livelihoods and financial stability, is making asset managers think harder about nature risk and the environmental dependencies in investee companies.
EMD: On the bread line
6 Jul. 2022
Russia’s war in Ukraine has contributed to soaring food prices, supercharging global inflation. Poorer countries will likely be hardest hit, adding to the risk of social unrest. With public finances and incomes already under strain, emerging-market debt investors should be on high alert.
Investing in a just transition to net zero: A Q&A with Nick Robins
30 Jun. 2022
Reaching net zero by 2050 will require significant injections of capital. But it is also an opportunity to rethink social relationships, as Professor Nick Robins explains.
Supply chains, painkillers and gene editing: ESG risks in pharma
29 Jun. 2022
Reflecting on ESG risks in the pharmaceutical industry, Sora Utzinger discusses supply chains and counterfeit medicines, access to painkillers, and the ethics of gene editing.
What does the data say? Biodiversity loss: From horror to hope
24 Jun. 2022
In this month’s instalment of our visual series on topical themes, we explore the world of biodiversity.
ESG investing: Lasting lessons from Russia’s war on Ukraine
23 Jun. 2022
Russia’s invasion of Ukraine has led to ESG receiving widespread flak. While much of the criticism is unjustified, the episode underlines how many issues related to ESG are complex and involve trade-offs. Investment approaches may need fine tuning, especially if the geopolitical landscape continues to change so rapidly.
Antimicrobial resistance: Q&A with Dame Sally Davies
10 Jun. 2022
Resistance to antibiotics is already killing millions. Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, spoke to AIQ on the latest developments to counter antimicrobial resistance Antimicrobial Resistance (AMR) in the UK and globally.
The AIQ Podcast: Investing towards a new social contract
9 Jun. 2022
As life returns to some form of normality, governments are free to move their focus from COVID-19 to left-behind communities and delivering a just transition. This is important to secure long-term economic outcomes, but also comes with investment opportunities and risks.
Deep water: Ten threats to marine ecosystems
8 Jun. 2022
Our air, weather, food, the health of diverse marine life and millions of jobs all depend on the ocean. But we have not done well as custodians of marine ecosystems. Here, we set out ten ways where human actions threaten the health of an essential environment.
Multi-asset allocation views: Central banks’ delicate balancing act
6 Jun. 2022
With high levels of inflation persisting around the world, central banks must tighten policy without hurting consumer demand and economic growth. This will be more difficult for some central banks than others, says Sunil Krishnan.
Our progress towards net zero in real assets: A Q&A with Ed Dixon
30 May 2022
One year on from publishing our 2040 net-zero pathway for real assets, Ed Dixon talks through some of the key highlights, challenges and priorities for 2022.